NCT06371326 - A Study of ZT002 Injection in Participants With Overweight or Obesity | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 21, 2023

Primary Completion Date

August 30, 2024

Study Completion Date

September 30, 2024

Conditions

Overweight or Obesity

Interventions

DRUG

ZT002 Injection

Participants will receive ZT002 by subcutaneous (SC) injection.

DRUG

Placebo

Participants will receive Placebo by subcutaneous (SC) injection.

Trial Locations (1)

First Affiliated Hospital of Bengbu Medical College, Bengbu